Atsena Completes Part B Dosing and Advances to Pivotal Part C of LIGHTHOUSE Trial (Atsena Therapeutics)
UF startup Atsena Therapeutics announced that dosing is complete in patients enrolled across all adult and pediatric cohorts in Part B of the Phase I/II/III Lighthouse Trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Researchers Find Vital Clue in the Progression of Type 1 Diabetes (UF Health)
UF researchers have added an important piece to the puzzle in understanding the progression of type 1 diabetes.
With Startup, Researchers Plan To Help Growers Feed More People, Preserve Environment (UF News)
UF startup EZ Ag Innovations, founded by UF researchers Nathan Boyd and Arnold Schumann, is using AI-powered precision-spraying technology to help farmers reduce chemical use, lower costs, and improve sustainability in agriculture.
Rise Therapeutics Secures New Funding To Advance First-in-Class R-2487 Oral Immune Biomodulator Into Sjogren’s Disease Clinical Testing (Bio Space)
UF startup Rise Therapeutics, a clinical-stage biotechnology company developing a novel class of oral targeted immunotherapies, announced it will be initiating clinical evaluation of R-2487 in SjD.
Scientists Discover New Target in Potential Pancreatic Cancer Treatment (UF Health)
UF researchers helped find a promising new way to attack and kill pancreatic cancer cells by identifying an overlooked weak spot on a protein that supercharges the lethal cancer’s growth.
Atsena Therapeutics Announces Dosing Complete for Adults in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-Linked Retinoschisis (Globe Newswire)
UF startup Atsena Therapeutics announced that dosing is complete in adults enrolled in Part B of the LIGHTHOUSE study, the Phase I/II/III clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Optym Launches LoadAi, Bringing Real-Time Decision Intelligence to Truckload Dispatching (Cision PR Web)
UF startup Optym announced the launch of LoadAi, an AI-powered operations platform built to help truckload carriers reduce empty miles, optimize dispatch decisions, and scale planner productivity across their networks.
LightPath Technologies Awarded $22.1 Million Follow-On Purchase Order To Supply Advanced Infrared Camera Systems (PR Newswire)
UF startup LightPath Technologies, Inc., announced it has secured $22.1 million in follow-on purchase orders with a leading global technology customer related to the supply of advanced infrared camera systems in CY 2027.
AI Detects Hidden Movement Clues Linked to Brain Disorders, Study Shows (UF News)
UF researcher Diego L. Guarín is using AI to detect subtle motor changes from video recordings, aiming to identify Parkinson’s disease earlier than traditional clinical methods.
Kriya Announces $320 Million Series D Financing to Advance Pipeline of Gene Therapies for Chronic Diseases of High Unmet Need (Bio Space)
UF startup Kriya Therapeutics, Inc., a clinical-stage biopharmaceutical company developing gene therapies to address common chronic diseases of high unmet need, announced the closing of a $320 million Series D financing.